Modified CEA nucleic acid and expression vectors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 7, 2012
Grant Date -
Nov 11, 2010
app pub date -
Mar 2, 2010
filing date -
Apr 9, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully